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Abstract: B cells play a crucial role in the pathogenesis of rheumatoid arthritis. In Nkx2-3-deficient
mice (Nkx2-3−/−) the spleen’s histological structure is fundamentally changed; therefore, B cell
homeostasis is seriously disturbed. Based on this, we were curious, whether autoimmune arthritis
could be induced in Nkx2-3−/− mice and how B cell activation and function were affected. We induced
arthritis with immunization of recombinant human proteoglycan aggrecan G1 domain in Nkx2-3−/−
and control BALB/c mice. We followed the clinical picture, characterized the radiological changes,
the immune response, and intracellular Ca2+ signaling of B cells. Incidence of the autoimmune
arthritis was lower, and the disease severity was milder in Nkx2-3−/− mice than in control BALB/c
mice. The radiological changes were in line with the clinical picture. In Nkx2-3−/− mice, we measured
decreased antigen-induced proliferation and cytokine production in spleen cell cultures; in the sera,
we found less anti-CCP-IgG2a, IL-17 and IFNγ, but more IL-1β, IL-4 and IL-6. B cells isolated from
the lymph nodes of Nkx2-3−/− mice showed decreased intracellular Ca2+ signaling compared to those
isolated from BALB/c mice. Our findings show that the transcription factor Nkx2-3 might regulate
the development of autoimmune arthritis most likely through modifying B cell activation.
Keywords: autoimmune arthritis; Nkx2-3; B cell activation
1. Introduction
Rheumatoid arthritis (RA) is the most frequent systemic autoimmune disease in the
Western-European and North-American countries [1]. The disease primarily affects the small joints,
where a chronic, progressive inflammation leads to cartilage and bone destruction, associated with
severe pain and disability [1]. Despite intensive research, no definitive cause(s) of the disease are known,
and therefore, unfortunately, no curative treatment is available to date [2]. So, finding the potential
pathogenic factors and mechanisms in the background of RA is of utmost importance because they might
provide a basis for future therapies. In this regard, mouse models of RA are extremely useful because
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several aspects of the disease can be studied more efficiently than in humans [3]. Especially those
models are beneficial, which share many features of RA, like proteoglycan-aggrecan-induced arthritis
(PGIA) [4] and its refined version, recombinant human G1 domain-induced arthritis (GIA) [5]. (P)GIA
is similar to RA in many respect: (i) clinical picture [4,5], (ii) histological changes [4,5], (iii) radiological
changes [4,6], (iv) autoreactive T cell activation [7], (v) Th1 and Th17 differentiation [8], (vi) production
of autoantibodies (both against the mouse cartilage aggrecan and citrullinated antigens) [5] and (vii)
proinflammatory cytokines was described [5].
RA is a chronic, progressive disease, usually lasting for decades [2,9,10]. According to our present
view on RA pathogenesis, the patients are diagnosed only in the final inflammatory/destructive phase
of the disease, when the typical symptoms (pain, swollen joints) appear [10]. However, the loss
of tolerance and the development of symptomless autoimmunity precedes this usually by several
years [10]. The dysregulation of the immune system might be the result of the interplay between genetic
(MHC and non-MHC genes), epigenetic and environmental factors (infections, diet, smoking) [9,10].
The development of autoreactive T cells and starting of autoantibody production might be the key
elements of this preclinical/latent phase of RA [10] and likewise, during the initiation period of its
model PGIA [8]. These processes most likely take place not only locally, in the joints, but, importantly,
in the lymphatic tissues like the lymph nodes and the spleen [2,8].
The spleen is well known for its function in the degradation of red blood cells and the immune
response against blood-borne antigens, especially those of encapsulated bacteria [11,12]. Moreover,
the spleen is critical for B cell development and, uniquely, all major peripheral B cell populations (B1a-,
B1b-, B2-, marginal zone (MZ) B cells) can be found here. Not much is known about the exact role
of the spleen in RA, however, based on mouse models of GIA and collagen-induced arthritis (CIA),
we might suspect a potential involvement: increased size and more activated cells can be detected in
spleens from both GIA (own unpublished observation) or CIA mice [13].
Nirenberg-Kim (NK) 2 homeobox 3 (Nkx2-3) is a homeodomain transcription factor, which is
essential for the normal development of the spleen, Peyer’s patches and small intestine [14–17].
Along with its role in the development of intestinal lymphoid tissues. Nkx2-3 is crucial for the
expression and regulation of the mucosal addressin cell adhesion molecule-1 (MADCAM-1) on the
spleen sinus lining cells and on high endothelial venules of the mesenteric lymph nodes and Peyer’s
patches [17–20]. Nkx2-3 has an important role in spleen organization and function, since it controls the
correct micro-environment for B cell maturation and T-cell-dependent (TD) immune reaction [14,21].
Its absence results in disorganized germinal center (GC) formation leading to abnormal secondary
B cell differentiation and decreased antibody response with minimal affinity maturation [21,22].
Nkx2-3-deficient mice (Nkx2-3−/−) are either asplenic or have a significantly reduced spleen size with a
lack of the marginal zone [21]. In response to the TD antigen, the number of circulating lymphocytes
of the Nkx2-3−/− mice was found to be increased compared to both Nkx2-3+/− and Nkx2-3+/+ [21]
indicating their altered distribution between peripheral lymphoid tissues. Moreover, Nkx2-3−/− mice
showed an elevation in the number of the B cells in mesenteric lymph nodes which may be due to
the abnormal development of the small intestine and the Peyer’s patches of these mice, and also a
significant increase in the number of the IgM+ B cells in the bone marrow (BM) [21].
In humans, overexpression of Nkx2-3 was found to be associated with both Crohn’s disease and
ulcerative colitis through its effect on the regulation of PTPN2 expression, VEGF and MADCAM-1
signaling, and the production of endothelin-1 [16,18,23,24]. Additionally, Robles and colleagues
reported that chromosomal translocation of Nkx2-3 gene alongside with immunoglobulin heavy chain
gene (IGH), resulted in irregular B cell receptor signaling leading to the MZ B cell lymphomagenesis,
through the activation of the NF-KB and PI3K-AKT pathways [25].
Our aim in this study was to investigate the effect of Nkx2-3 deficiency in GIA, a mouse model of
autoimmune arthritis, and study the effect of Nkx2-3 absence on B cell signaling and activation. Here,
we report for the first time that GIA can be induced in Nkx2-3−/− mice, although with lower incidence,
decreased severity and less joint destruction. We measured decreased T cell proliferation and cytokine
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production in spleen cultures. We found less anti-CCP-IgG2a, IL-17 and IFNγ, but more IL-1β, IL-4
and IL-6 in the sera. Finally, B cells of Nkx2-3−/− mice showed decreased intracellular Ca2+ signaling
compared to those isolated from BALB/c mice. Collectively, these data indicate that Nkx2-3 mice are
relatively resistant to GIA-induction which correlates with their impaired in vitro B cell responsiveness.
2. Results
2.1. Decreased Severity and Incidence of rhG1-Induced Arthritis in Nkx2-3 Knock-Out Mice
The spleen plays a critical role in the correct development and recirculation of B cell populations.
The connection between the peritoneal B cell pool and the splenic B cells is also well established [26].
Recombinant human G1-induced arthritis is provoked by repeated intraperitoneal injections of the
aggrecan G1 domain in the dimethyl-dioctadecyl-ammonium (DDA) adjuvant. By intraperitoneal
immunization the first antigen encounter occurs in the peritoneal cavity, but soon the antigen is
transported to other lymphoid tissues like the local lymph nodes through lymph vessels and the spleen
through blood vessels. In GIA, both the local peritoneal activation of immune cells and the activation
of the splenic cells are thought to be critical for the development of autoimmune arthritis [8].
Since Nkx2-3 knock-out mice were present with severe splenic developmental defects, we were
curious to test whether rhG1-induced arthritis could be observed in them. To this end, we immunized
Nkx2-3−/− and wild-type control BALB/c mice side-by-side. Nkx2-3−/− mice developed arthritis;
however, to a lesser extent than the control BALB/c mice indicated by both the lower clinical severity
scores (9.2 ± 1.0 in Nkx2-3−/− versus 13.0 ± 0.9 in BALB/c controls at Day 61) (Figure 1A) and the
lower incidence (~70% in Nkx2-3−/− versus >90% in BALB/c controls after the third immunization)
(Figure 1B). The clinical scores were supported by the limb thickness measurements, too. We measured
the wrist (Figure 1(Ca)), leg (Figure 1(Cb)) and ankle (Figure 1(Cc)) thickness two weeks after the third
immunization. We found that in arthritic Nkx2-3−/− mice, the limbs were significantly less swollen
(Figure 1(Ca–Cc)) indicating a lower degree of inflammatory edema. Interestingly, in Nkx2-3−/− mice,
the disease progression was also different from that seen in BALB/c mice: in GIA, typically, the arthritis
develops progressively and once established it will not regress, however, in the case of Nkx2-3−/− mice
we have seen the undulation of paw inflammation in some cases.
2.2. Micro-CT Imaging Confirmed Decreased Cartilage and Bone Destruction in Arthritic Nkx2-3
Knock-Out Mice
Next, we wanted to visualize the radiological changes induced by GIA in Nkx2-3−/− and
control BALB/c mice. RA causes not only cartilage destruction but the adjacent bone is always
affected as a result of the inflammation-induced osteoclast activity. Typical changes associated with
RA are bone loss, osteophyte formation and, in the latter stages of the disease, ankylosis. So,
we performed a micro-CT analysis of arthritic Nkx2-3−/− and control BALB/c mice. As shown by the
pseudocolor enhanced micro-CT images wild-type mice demonstrated marked osteophyte formation
and bone surface irregularity predominantly in the tarsal and metatarsal region (Figure 2A,C,E).
In comparison, Nkx2-3−/− animals showed less severe detrimental bone structural damage secondary to
the autoimmune arthritis manifested by a more limited surface porosity and periarticular inflammatory
osteoporosis (Figure 2A,C,E).
We also analyzed the micro-CT scans for some quantitative markers of the bone microarchitecture,
e.g., number (Po.N), volume (Po.V) and surface of bone pores (Po.S), and the bone surface/Total Volume
(BS/TV) values. In arthritic Nkx2-3 KO mice, the slightly decreased Po.N together with the increased
Po.V and Po.S values could be due to decreased reactive bone formation, whereas the slightly decreased
BS/TV value might indicate less osteophyte formation, all of which correlate with the milder arthritis
(Figure A1).
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intraperitoneally three times every third week. The severity score (A) and incidence (B) of the induced 
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Severity of the disease was determined every second day with the help of a scoring system ranging 
from 1 to 4, based on the swelling, redness and ankylosis of the joints of the paws. Clinical scores are 
visualized as mean ± standard error of mean (SEM). The thickness of the limbs (C) were measured 
with a digital caliper two weeks after the third immunization. The diagrams show the thickness 
values of the wrist (C/a), legs (C/b) and ankles (C/c) as mean ± SEM. Statistically significant differences 
(∗ p < 0.05) are indicated. 
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2.3. Comparison of the G1-Specific Immune Response between Nkx2-3−/− and BALB/c Mice
Given the lower severity and incidence of autoimmune arthritis in the Nkx2-3−/− mice, next, we
wanted to characterize the immune response against the G1 antigen and correlate it to the clinical picture.
At the end of the experiments, mice were sacrificed and their spleens and sera were harvested for in vitro
assays similarly to previous studies [5,27]. In the in vitro studies, we divided the Nkx2-3−/− mice into
arthritic and nonarthritic subgroups to see the possible differences in the immunological parameters.
First, we characterized the antigen-induced proliferation of spleen cells. We found significantly
decreased proliferation in both arthritic and nonarthritic Nkx2-3−/− mice compared to the arthritic
BALB/c mice (Figure 3A). Since Th1, Th2 and Th17 cytokines play a pivotal role in the regulation of
GIA [8,28], next, we measured the cytokine production of the rhG1-stimulated spleen cell cultures
(Figure 3B). We found that Nkx2-3−/− spleen cells produced significantly less IL-4, IL-6 and IFNγ and
markedly, but not significantly, less IL-17 than the corresponding BALB/c spleen cells (Figure 3B).
There was no difference in the TNFα production of splenocytes isolated from Nkx2-3−/− or control
BALB/c mice (Figure 3B). Of note, nonarthritic Nkx2-3−/− spleen cells produced no detectable amount
of the tested cytokines even in the presence of rhG1.
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densities (violet and blue colors indicate low density-; yellow, red and green colors indicate high-
density areas, respectively). The white dashed line-surrounded rectangular areas indicated in A/b, 
B/b, C/b and D/b are shown with higher magnification in A/c, B/c, C/c and D/d. 
We also analyzed the micro-CT scans for some quantitative markers of the bone 
microarchitecture, e.g., number (Po.N), volume (Po.V) and surface of bone pores (Po.S), and the bone 
surface/Total Volume (BS/TV) values. In arthritic Nkx2-3 KO mice, the slightly decreased Po.N 
together with the increased Po.V and Po.S values could be due to decreased reactive bone formation, 
whereas the slightly decreased BS/TV value might indicate less osteophyte formation, all of which 
correlate with the milder arthritis (Figure A1). 
2.3. Comparison of the G1-Specific Immune Response between Nkx2-3−/− and BALB/c Mice 
Given the lower severity and incidence of autoimmune arthritis in the Nkx2-3−/− mice, next, we 
wanted to characterize the immune response against the G1 antigen and correlate it to the clinical 
2. c i of the bone microarchitectural changes caused by GIA in Nkx2-3−/−
tr l BALB/c mice. Arthrit c Nkx2-3−/ (n = 2) and control BALB/c (n = 2) mice w re an sth tized an
micro-CT scan were made from the right hind l mbs. Representative images show the dorsal (A) and
(B) or plantar (C,D) or side views (E,F) of the arthritic legs from BALB/c (A,C,E) and Nkx2-3−/− (B,D,F)
mice respectiv ly. Pseudocolored imag s (A/b,c, B/b,c, C/b,c, D/b,c, E,F) show the bone densities
(viole and blu colors indi ate low ensity-; yellow, red and green colors indicate high-density areas,
respectively). The white dashed line-surrounded rectangular areas indicated in A/b, B/b, C/b and D/
are shown with high r mag ification in A/c, B/c, C/c a d D/d.
Int. J. Mol. Sci. 2020, 21, 6162 6 of 16
Int. J. Mol. Sci. 2020, 21, x 6 of 16 
picture. At the end of the experiments, mice were sacrificed and their spleens and sera were harvested 
for in vitro assays similarly to previous studies [5,27]. In the in vitro studies, we divided the Nkx2-
3−/− mice into arthritic and nonarthritic subgroups to see the possible differences in the immunological 
parameters. 
First, we characterized the antigen-induced proliferation of spleen cells. We found significantly 
decreased proliferation in both arthritic and nonarthritic Nkx2-3−/− mice compared to the arthritic 
BALB/c mice (Figure 3A). Since Th1, Th2 and Th17 cytokines play a pivotal role in the regulation of 
GIA [8,28], next, we measured the cytokine production of the rhG1-stimulated spleen cell cultures 
(Figure 3B). We found that Nkx2-3−/− spleen cells produced significantly less IL-4, IL-6 and IFNγ and 
markedly, but not significantly, less IL-17 than the corresponding BALB/c spleen cells (Figure 3B). 
There was no difference in the TNFα production of splenocytes isolated from Nkx2-3−/− or control 
BALB/c mice (Figure 3B). Of note, nonarthritic Nkx2-3−/− spleen cells produced no detectable amount 
of the tested cytokines even in the presence of rhG1. 
 
Figure 3. The comparison of the rhG1-induced immune response in Nkx2-3−/− (n = 9) and control 
BALB/c (n = 9) mice. Nkx2-3−/− mice were divided into arthritic (n = 5) and nonarthritic (n = 4) 
subgroups during the analysis. In all diagrams (A–F), bars show the mean ± SEM values calculated 
from n = 5 arthritic Nkx2-3−/− mice (black), n = 4 nonarthritic Nkx2-3−/− mice (gray) and n = 9 arthritic 
control BALB/c mice (white). Statistically significant differences (∗ p < 0.05) are indicated. (A) 
. t rh 1-i i response in Nkx2-3−/ ( )
i . - /− mice were divided into arthritic (n 5) a rt ritic
during the analysi . In all diagrams (A–F), bars show the m an± SEM values calcul ted from
n = 5 arthritic Nkx2-3−/− mice (black), n = 4 nonarthritic Nkx2-3−/− mice (gray) and n = 9 arthritic control
BALB/c mice (white). Statistically significant differences (∗ p < 0.05) are indicated. (A) Proliferation of
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the stimulation index (SI) calculated as a ratio of stimulated/nonstimulated values of the same mice.
(B) In vitro cytokine production of spleen cells was tested after incubation in the presence or absence
of rhG1 for 5 d. Cell culture supernatants were harvested and the specific cytokine concentrations
were measured by sandwich ELISA. Note, spleen cells from the nonarthritic Nkx2-3−/− group did not
produce any measurable amount of cytokines. (C) The serum anti-rhG1-specific IgG1 antibodies were
measured using indirect ELISA. Sera were diluted at 1:8000. Bars show the optical density values
measured at 492 nm. (D,E) The serum anti-CCP-specific IgG1 and IgG2a antibodies were measured
using indirect ELISA. Sera were not diluted. Bars show the optical density values measured at 450 nm.
(F) Serum cytokine levels were measured with sandwich ELISA.
Antibody production is an important laboratory parameter of GIA correlating with the severity of
the disease [5]. So, after the characterization of the cellular immune response, we went on to measure the
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joint inflammation-related serum antibody levels of Nkx2-3−/− and BALB/c mice. We found significantly
decreased anti-rhG1 (Figure 3C) and anti-CCP (Figure 3D) IgG1 levels in the nonarthritic Nkx2-3−/−
mice sera compared to the arthritic BALB/c controls. The arthritic Nkx2-3−/− mice had similar levels
of anti-rhG1 (Figure 3C) and anti-CCP (Figure 3D) IgG1 to the arthritic BALB/c mice. Furthermore,
the anti-CCP-IgG2a levels were lower (but not significantly) in both arthritic and nonarthritic Nkx2-3−/−
mice than in arthritic BALB/c controls (Figure 3E). In line with our expectations, we found that the sera
of nonarthritic Nkx2-3−/− mice contained lower levels of anti-rhG1 and anti-CCP IgG1 when compared
to the arthritic Nkx2-3−/− sera (Figure 3C,D). In contrast, there was no significant difference between
the anti-CCP IgG2a levels of the sera from arthritic or nonarthritic Nkx2-3−/− mice (Figure 3E).
Finally, we compared the serum pro- and anti-inflammatory cytokine concentrations of Nkx2-3−/−
and BALB/c mice. We found markedly, but not significantly, elevated serum levels of IL-1β, IL-4, IL-6
and TNFα and markedly decreased IL-17 and IFNγ in arthritic Nkx2-3−/− mice when compared to
the arthritic BALB/c controls (Figure 3F). In the case of IL-1β, IL-4 and IL-6, the serum concentrations
were markedly, but not significantly, higher in the arthritic than in the nonarthritic Nkx2-3−/− sera
(Figure 3F).
2.4. Comparison of the Ca2+-Signaling in B and T Cells of Nkx2-3−/− and BALB/c Mice
Since we found significant differences in the rhG1-induced immune responses of the Nkx2-3−/−
and BALB/c mice, we were curious about what could be in the background of such variations. In the
case of GIA, similarly to RA, close cooperation between T and B cells is necessary for the development
of autoimmunity [7]. Since the Nkx2-3 mutation affects mostly the B lymphocyte development and
recirculation, we hypothesized that the activation of B cells might be impaired, which, in turn, led to
ameliorated arthritis. To characterize the activation of the B cells, we isolated the inguinal and
mesenteric lymph nodes from Nkx2-3−/− or BALB/c control mice and loaded the lymphocytes with
the Ca2+-specific indicator Fluo-3. Then, we activated the B cells with cross-linking of the BcR with
anti-IgM or IgG antibodies and followed the intracellular Ca2+ signals (Figure 4).
We found significantly lower anti-IgM or anti-IgG-induced Ca2+-signal in the B cells isolated
from the inguinal lymph nodes of Nkx2-3−/− mice than those from BALB/c (Figure 4A,C). Similarly, B
cells isolated from the mesenteric lymph nodes, showed decreased Ca2+-signal both after anti-IgM or
anti-IgG-activation (Figure 4B,D) when compared to BALB/c controls, however, these differences did
not reach statistical significance. Finally, although we were not expecting any changes in the T cell
activation in Nkx2-3−/− mice, we tested the Ca2+-signal of T cells after anti-CD3 cross-linking. As we
expected, the Ca2+-signals of T cells isolated from both the inguinal and mesenteric lymph nodes
were similar in Nkx2-3−/− and BALB/c mice indicating that, indeed, the Nkx2-3 mutation caused an
activation perturbance specifically in B cells.
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fluorescence (ratiometric with the intracellular Ca2+ level) as mean ± SEM values calculated from the
data of n = 3 Nkx2-3−/− and n = 3 BALB/c mice. * p < 0.05.
3. Discussion
In the present study, we set out to study how Nkx2-3-deficiency impacted the development
of autoimmune arthritis. To answer this question, we used a mouse RA model, GIA, whereby we
immunized Nkx2-3−/− and BALB/c control mice side-by-side with the rhG1 antigen. While the spleen
plays important roles in the T-dependent immune responses [11,29], and in GIA it also serves as
an activation niche for autoreactive lymphocytes [8,30], in Nkx2-3−/− mice, with severely damaged
spleen, GIA could still be induced. This result shows that in GIA the spleen’s role is not exclusive
in the activation of autoreactive lymphocytes, and confirms that the lymph nodes and perhaps other
lymphatic or extralymphatic tissues [8] may play an equally important role in the disease induction.
On the other hand, we observed lower incidence and decreased arthritis severity in the Nkx2-3−/−
mice compared to t e wild-type controls, thus, the splenic defects had a significant impact on the
rhG1-induced immune reaction. During the induction of (P)GIA, we immunized the mice with PG
extracts/rhG1 and DDA intraperitoneally which led to the local activation of T lymphocytes both in
the peritoneal cavity and the mesenteric lymph nodes followed by the systemic immune response in
which the spleen is involved [8]. The local activation of Th1 and Th17 cells in the peritoneal cavity is of
special importance because it was a specific feature of BALB/c mice which are the only susceptible
mouse strain for (P)GIA [8]. The present results in Nkx2-3−/− mice might also support this: the local
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peritoneal activation could remain unchanged, however, the systemic response, developing in the
spleen is missing, which could be responsible for the weaker arthritis.
As it was previously described there is a significant B cell trafficking between the peritoneal
cavity and the spleen [26]. Although there was a preferential homing of the peritoneal B1 and B2
cells towards other serosa surfaces like the pleura, however, some B1 and B2 cells migrated from
the peritoneal cavity into the spleen [26]. Since in Nkx2-3−/− mice, the spleen microarchitecture is
seriously defective, with abnormal adhesion molecule expression and vessel formation [29] most
likely, the above-mentioned B cell trafficking is defective [29], in addition to the absence of MZ B cells
involved in antigen delivery for GC initiation [21]. B lymphocytes not only play a role as precursors
for antibody-producing plasma cells in autoimmune arthritis but have an equally important role as
antigen-presenting cells [31]. Based on the above-mentioned works [26,29], we propose that the local,
peritoneal antigen presentation by B cells could remain unchanged, however, due to the potential lack
of splenic homing (and the severely reduced GC formation in the spleen upon T-dependent antigen
challenge [21]), the systemic activation could be impaired. The subsequently weaker immune response
is mirrored in the decreased splenic proliferation and cytokine production. This was particularly
pronounced in the case of lymphocyte-derived cytokines (IL-4, IL-6, IL-17 and IFNγ), but, in the case
of TNFα, we measured approximately equal amounts in Nkx2-3−/− and control BALB/c spleen cell
cultures, showing that the macrophages were not affected.
In humans, the potential pathogenic role of the Nkx2-3 transcription factor was found in
inflammatory bowel diseases (Crohn’s and ulcerative colitis) so far [23,24] and also suggested in
spondylarthritis more recently [32]. In mice, the absence of Nkx2-3 proved to be protective in
DSS-induced colitis through an IL-22-independent mechanism [18]. To our knowledge, this was the
first experiment where the Nkx2-3−/− mutation was investigated in the context of autoimmune arthritis.
Based on the data presented in this study, Nkx2-3 is not only involved in intestinal inflammatory
diseases, but also affects autoimmune arthritis.
An important finding of the present study was that not all Nkx2-3−/− mice developed arthritis
upon rhG1 immunization: in all experiments, 20–40% of Nkx2-3−/− mice remained healthy contrary to
BALB/c mice (>90% incidence, as seen here and in previous studies [5,27]). To decipher what could be
the reason why certain immunized mice did not develop arthritis, we analyzed their immune response
parameters separately. We measured considerably lower anti-rhG1 and anti-CCP IgG1 antibody levels
in the sera of nonarthritic than in the sera of arthritic Nkx2-3−/− mice, respectively. This alone could
explain the differences in the arthritis, since it has been shown in several earlier studies that the serum
antibody levels against the proteoglycan aggrecan (and its immunodominant region: G1 domain) and
CCP show the strongest correlation with the severity of GIA [33,34]. Furthermore, in nonarthritic
Nkx2-3−/− mice, the serum concentrations of IL-1β, IL-4 and IL-6 were lower than in arthritic Nkx2-3−/−
mice. We hypothesize that in those Nkx2-3−/− mice, which did not develop arthritis, the B cell activation
and/or antigen presentation was inadequate to induce sufficient antibody production and autoreactive
T cell activation. However, further and more detailed investigation would be needed to adequately
answer this question.
Even in those Nkx2-3−/− mice which did develop GIA, there were significantly milder symptoms
(lower clinical scores, lesser edema, radiologically decreased cartilage and bone destruction). This was
in line with those serum parameters which were clearly different from the control BALB/c mice.
Specifically, although the anti-rhG1 and anti-CCP-IgG1 antibody levels were similar in the arthritic
Nkx2-3−/− mice and the controls, the anti-CCP-IgG2a antibodies were produced in lesser amounts.
Additionally, the concentrations of signature cytokines of GIA [5], and likewise, RA [2], IFNγ and IL-17
were markedly lower, whereas the concentrations of IL-1β, IL-4 and IL-6 were markedly higher in
Nkx2-3−/− than in BALB/c mice. Overall, these markers suggest a stronger Th2 activation (primarily
indicated by IL-4 and anti-CCP IgG2a) in Nkx2-3−/− mice instead of the characteristic Th1/Th17
dominated immune response seen in GIA of BALB/c mice [5,8,28]. Since Th2 cytokines have primarily
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anti-inflammatory effects [11] and have been shown to ameliorate PGIA [35], we suggest that this
slight shift towards Th2 measured in Nkx2-3−/− mice might explain the milder arthritis.
As described here, and earlier [5], similarly to RA, in GIA mice significant anti-CCP antibody
production can be detected. The process of citrullination and the role of autoantibodies against these
modified antigens is of special interest in RA. ACPA production is promoted by environmental factors
like smoking and genetic predispositions such as HLA-DRB1 [36]. Several studies reported that ACPA
positive patients are prone to have more joint erosions [36,37]. ACPA form immune complexes with
the citrullinated peptides leading to the activation of macrophages and proinflammatory cytokine
production, as well as osteoclastogenesis [36,37]. ACPA is highly specific to RA and can be early
detected, even before the onset of RA. Therefore, it is used as a specific diagnostic marker for RA [38].
Recently, it was also found that the pathogenic ACPA are hyperglycosylated which might be regulated
by Th17 cells [37]. Since in GIA Th17 activation was observed it is tempting to speculate that altered
glycosylation might also occur which could contribute to the pathologic immune reaction against the
cartilage antigen components.
Finally, to find a cellular mechanism in the background of the above-detailed immune response
differences, we turned our attention to the activation of B cells. B cell activation starts with the
engagement of the BcR by the antigen and followed by a well-characterized line of biochemical events
including the phosphorylation of cytoplasmic signaling proteins and the transient elevation of the
cytoplasmic Ca2+-level [11]. We studied the latter and found that in mesenteric and inguinal lymph
node B cells of Nkx2-3−/− mice, in vitro stimulation with both anti-mouse IgM and anti-mouse IgG
caused a weaker Ca2+-signal compared to BALB/c controls. At the same time, the Ca2+-signal in
Nkx2-3−/− T cells remained unchanged, showing that this was a B-cell-specific alteration. This decreased
B cell activation capacity of Nkx2-3−/− mice was also seen on phospho-blots from some preliminary
experiments (data not shown), however, further analysis is needed to clarify which protein(s) could be
involved in the signaling changes. These data are in harmony with those described earlier: increased
expression of Nkx2-3 in B cells led to Syk and Lyn phosphorylation, elevated basal Ca2+-level and
anti-IgM-induced Ca2+-signal [25], the exact opposite to what we found here, in the absence of
Nkx2-3. The decreased antigen-driven B cell activation could lead to weaker B cell proliferation
and differentiation which, in turn, could explain the less pronounced immune response and the
consequently milder autoimmune arthritis.
In conclusion, the complex immune response changes in Nkx2-3−/− mice due to the defective spleen
structure and function could explain the reduced severity and lower incidence of autoimmune arthritis.
At the cellular level, we found weaker B cell activation which might, at least in part, be responsible for
the altered immune response. These data add to our knowledge about the significance of the spleen in
the development of autoimmunity, and hopefully serve as a starting point for future studies.
4. Materials and Methods
4.1. Mice
We used 4–5 months old [39] female Nkx2-3-deficient (Nkx2-3−/−) [29] and BALB/c mice.
Animals were kept and bred in the transgenic mouse facility of the Department of Immunology
and Biotechnology under conventional conditions at 24 ± 2 ◦C with a controlled 12/12 h light/dark
cycle. Mice used in experiments were housed in groups of five and they received acidified water and
food ad libitum.
All animal experiments were performed in accordance with the regulations set out by the Animal
Welfare Committee of the University of Pécs (BA02/2000-48/2017 (06/27/2017)).
4.2. Induction and Assessment of Recombinant Human G1-Induced Arthritis
To induce arthritis, Nkx2-3−/− and BALB/c mice were immunized side-by-side as described
previously [5]. Briefly, mice received intraperitoneal injections of 40 µg rhG1 antigen mixed with
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dimethyl-dioctadecyl-ammonium (DDA) adjuvant dissolved in PBS, on Days 0, 21 and 42. The clinical
signs of arthritis were monitored regularly after the second immunization: all mice were examined
every second day and the symptoms were quantified using a clinical scoring system ranging from 0 to
4 based on the swelling, redness and ankylosis of the joints of the paws (maximum possible score 16) as
described before [4,5]. The diameters of the inflamed front and hind paws and ankles were measured
using digital calipers with an accuracy of 0.01 mm two weeks after the third immunization. Three
weeks after the last immunization, mice were sacrificed, then blood sera, spleens and lymph nodes
were collected for further in vitro studies.
4.3. Micro-CT
The right hind paws of mice were scanned under anesthesia with i.p. ketamine (120 mg/kg;
Calypsol, Gedeon Richter, Budapest, Hungary) and xylazine (6 mg/kg; Sedaxylan, Eurovet Animal
Health, Bladel, The Netherlands) using a SkyScan 1176 in vivo micro-CT system (Bruker, Kontich,
Belgium). A 0.5 mm Al filter was used, the voxel size was 17.5µm, tube voltage was 50 kV,
tube current was set to 500 µA. 3D reconstructions of the scans were made with the CT Analyzer
software, and representative pseudocolor images were generated to highlight bone erosions and
osteophyte formation.
4.4. In Vitro Spleen Cell Culture
Spleens were isolated and homogenized mechanically, then the spleen cells were cultured in
DMEM supplemented with 10% fetal calf serum on 48-well plates (1.8× 106 cells in 600µL medium/well),
in the presence or absence of 1.5 µg rhG1 antigen for 5 d. Supernatants were collected and stored in
−20 ◦C and later used for ELISA measurements.
4.5. Antigen-Specific Proliferation Assay
Another part of the spleen cells were cultured in DMEM supplemented with 10% fetal calf
serum, in the presence or absence of 1.5 µg rhG1 antigen in triplicates on 96-well plates (3 × 105
cells in 200 µL medium/well) for 5 d. Promega CellTiter96® Nonradioactive Cell Proliferation
Assay (Promega, Madison, WI, USA) was used to measure the proliferation rate according to the
manufacturer’s instructions.
4.6. ELISA Measurements
The specific cytokine concentrations (IL-1β, IL-4, IL-6, IL-17, IL-23, IFN-γ and TNF-α) were
measured in the blood sera and the supernatants of in vitro-cultured spleen cells using sandwich
ELISA (R&D Systems, Minneapolis, MN, USA), according to the manufacturer’s instructions.
The serum-concentration of rhG1 antigen-specific antibodies was measured using indirect ELISA
as described earlier [27]. Briefly, 96-well ELISA plates were coated overnight at room temperature with
the rhG1 antigen (0.1 µg/well in 100 µL carbonate coating buffer). After overnight incubation, plates
were incubated for 1 h with 1.5% nonfat dry milk (NFDM) in PBS blocking buffer, followed by washing
5 times with 0.5% Tween in PBS. Next, diluted sera were added to the plate and incubated for 2 h at
room temperature, then washed 5 times with 0.5% Tween in PBS. After that, anti-IgG1-peroxidase
(BD Bioscience, San Jose, CA, USA) secondary antibody was added to the plate and incubated for
2 h at room temperature. The results were detected using orthophenylenediamine chromophore and
H2O2 substrate.
The anti-CCP IgG1 and IgG2a antibody levels of sera were determined using the commercially
available Immunoscan CCP Plus ELISA kit (SVAR, Malmö, Sweden) with slight modification. For the
development of the reactions, we used anti-mouse-IgG1-peroxidase or anti-mouse-IgG2a-peroxidase
(both from BD Bioscience, San Jose, CA, USA) secondary antibody instead of the kit’s secondary reagent.
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4.7. Ca2+ Signaling Measurements
The intracellular Ca2+ levels were measured using a flow cytometer with the Fluo-3 indicator as
described before [40,41]. Briefly, single-cell suspensions were prepared from the lymph nodes of the
arthritic mice and suspended in RPMI supplemented with 5% FBS and 2M CaCl2 (1 × 106 cells/mL).
Cells were loaded with Fluo-3-AM (Invitrogen, Carlsbad, CA, USA) for 30 min at 37 ◦C in humidified
air with 5% CO2. Using a flow cytometer, we gated on the lymphocytes based on FSC/SSC parameter
distribution. The Fluo-3 fluorescence which is proportional to the intracellular Ca2+ level [40] was
detected in the FL1 channel. The baseline Fluo-3 fluorescence was measured for 1 min, then cells
were stimulated with anti-mouse-IgM, IgG, or anti-mouse CD3 followed by secondary anti-hamster
antibodies, measurements for five and a half minutes. Data were analyzed by the Cell Quest software
(BD Biosciences, San Jose, CA, USA). The FL1 mean fluorescence intensity values were calculated along
the time axis of the plots, and these were divided by the baseline fluorescence value, thereby the Ca2+
signal was expressed as FL1 change [41]. Please note that all Ca2+ measurements were performed
using unsorted lymph node cells and the B or T cell activation was only distinguished based on the
specific nature of the activation: anti-mouse-IgM or IgG activates only B cells through the BcR, whereas
anti-CD3 cross-linking activates T cells selectively.
4.8. Statistical Analysis
All values are presented as mean ± standard error of mean (SEM). Student’s t-test was used to
compare the experimental groups. p-values < 0.05 were considered statistically significant.
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a-CCP Anticyclic citrullinated peptide antibody
APCs Antigen-presenting cells
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GIA Recombinant human G1-induced arthritis
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IL Interleukin
MADCAM-1 Mucosal vascular addressin cell adhesion molecule 1
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NFDM Nonfat dry milk
NF-kB Nuclear factor kappa-light-chain-enhancer of activated B cells
Nkx2-3 Nirenberg-Kim (NK) 2 homeobox 3
Nkx2-3−/− Nkx2-3-deficient mouse (homozygous)
PBS Phosphate buffer solution
PI3K Phosphoinositide 3-kinases
PKB Protein Kinase B
PTPN2 Tyrosine-protein phosphatase nonreceptor type 2
RA Rheumatoid arthritis
rhG1 Recombinant human G1
RPMI Roswell Park Memorial Institute Medium
SSC Side scatter
TF Transcription factor
Th T helper cell
TNF-α Tumor necrosis factor α
VEGF Vascular endothelial growth factor
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Figure A1. Comparison of the quantitative markers of bone microarchitecture in arthritic Nkx2-3−/− and
BALB/c mice based on the micro-CT scans (representative images are shown in Figure 2). We compared
the bone pore number (Po.N) (A,B), volume (Po.V) (C,D) and surface (Po.S) (E,F), and the Bone
Surface/Total Volume (BS/TV) values (G,H) of the metatarsal (A,C,E,G) and tarsal (B,D,F,H) regions
from arthritic Nkx2-3−/− (black bars) and BALB/c (gray bars) mice, respectively. Bars show the mean ±
SEM values calculated from the data of 2 Nkx2-3−/− and 2 BALB/c mice.
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